Transcriptional stratification reveals distinct molecular subtypes with treatment-specific outcomes in multiple myeloma patients from the GEM2017FIT trial


Por: Porlan, A, Ariceta, B, Aguirre-Ruiz, P, De Las Heras, J, Medina, A, Gimenez, A, San Martin-Uriz, P, Larrayoz, MJ, Martinez-Lopez, J, Gonzalez-Calle, V, Puig, N, Calasanz, M, Gutierrez, N, Balari, AS, Romero, MTC, Oriol, A, Ocio, E, Dachs, LR, Bargay, J, Blanchard, MJ, Perianes, VC, Palacios, JJL, Creixenti, JBB, San-Miguel, J, Rodriguez-Otero, P, Mateos, MV and Prosper, F

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:


Filiaciones:
Porlan, A:
 Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

Ariceta, B:
 Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

Aguirre-Ruiz, P:
 Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

De Las Heras, J:
 Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain

Medina, A:
 Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain

Gimenez, A:
 Hosp 12 Octubre, Hematol Dept, Madrid, Spain

San Martin-Uriz, P:
 Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

Larrayoz, MJ:
 Clin Univ Navarra, CIMA LAB Diagnost, IdiSNA, Pamplona, Spain

Martinez-Lopez, J:
 Hosp 12 Octubre, Hematol Dept, Madrid, Spain

Gonzalez-Calle, V:
 Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain

Puig, N:
 Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain

Calasanz, M:
 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Clin Univ Navarra, CIMA LAB Diagnost, IdiSNA, Pamplona, Spain

Gutierrez, N:
 Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain

Balari, AS:
 Inst Catala Oncol ICO, Hematol Dept, Lhospitalet De Llobregat, Spain

Romero, MTC:
 Hosp 12 Octubre, Hematol Dept, Madrid, Spain

:
 Hosp Germans Trias i Pujol, Catalan Inst Oncol, Badalona, Spain

 Hosp Germans Trias i Pujol, Josep Carreras Inst, Badalona, Spain

Ocio, E:
 Univ Cantabria, Hosp Univ Marques de Valdecilla IDIVAL, Hematol Dept, Santander, Spain

Dachs, LR:
 Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hematol Dept, Barcelona, Spain

Bargay, J:
 Hosp Univ Son Llatzer, Hematol Dept, Palma De Mallorca, Spain

Blanchard, MJ:
 Hosp Univ Ramon y Cajal, Hematol Dept, Madrid, Spain

Perianes, VC:
 Univ Murcia, Virgen de la Arrixaca Univ Hosp, Hematol Dept, IMIB, El Palmar, Murcia, Spain

Palacios, JJL:
 Hosp 12 Octubre, Hematol Dept, Madrid, Spain

 Fdn PETHEMA, GEM, Madrid, Spain

Creixenti, JBB:
 Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hematol Dept, Barcelona, Spain

 Fdn PETHEMA, GEM, Madrid, Spain

San-Miguel, J:
 Fdn PETHEMA, GEM, Madrid, Spain

 Clin Univ Navarra, Hematol & Cell Therapy Dept, IdiSNA, Pamplona, Spain

 Clin Univ Navarra CCUN, Canc Ctr, Pamplona, Spain

Rodriguez-Otero, P:
 Clin Univ Navarra, Hematol & Cell Therapy Dept, IdiSNA, Pamplona, Spain

 Clin Univ Navarra CCUN, Canc Ctr, Pamplona, Spain

Mateos, MV:
 Hosp Univ Salamanca, Hematol Dept, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain

 Fdn PETHEMA, GEM, Madrid, Spain

Prosper, F:
 Ctr Invest Med Aplicada CIMA, Hematooncol Program, IDISNA, Pamplona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Clin Univ Navarra, Hematol & Cell Therapy Dept, IdiSNA, Pamplona, Spain

 Clin Univ Navarra CCUN, Canc Ctr, Pamplona, Spain
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas: 496-497
WOS Id: 001659530100047

MÉTRICAS